Optimal management of esophageal adenocarcinoma: should we be CROSS?

J Clin Oncol. 2014 Sep 20;32(27):3080-1. doi: 10.1200/JCO.2014.55.5243. Epub 2014 Jul 28.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Adenocarcinoma / therapy*
  • Carcinoma, Squamous Cell / therapy*
  • Chemotherapy, Adjuvant*
  • Esophageal Neoplasms / therapy*
  • Esophagectomy*
  • Esophagogastric Junction*
  • Female
  • Gastrectomy / adverse effects*
  • Humans
  • Male
  • Neoadjuvant Therapy*
  • Neoplasm Recurrence, Local / prevention & control*
  • Stomach Neoplasms / therapy*